Brochure
25 Jul 2024

Product Schedule

PDF 548 kB

We're focused on R&D and production of API and pharm-intermediates. The products which protected by valid patents are for labs R&D purposes only and are not offered for sales in countries where the sales of such products constitutes a patent infringement。

Content provided by our supplier

Jiangsu Bioscene Pharmaceutical Co.,Ltd

  • Country/Region:
    China
  • On CPHI since:
    2024
  • Certificates:
    1
  • Employees:
    50 - 99
Company types
Contract Research Organisation (CRO)
Primary activities
Chemical Development

Other Content from Jiangsu Bioscene Pharmaceutical Co.,Ltd ()